Urologie最新文献_第5页

[Early dissertation on endourology-life and work of Georg Adelmann (1811-1888)]. [早期关于内分泌学的论文——乔治·阿德尔曼（1811-1888）的生活和工作]。

IF 0.4 4区医学

Urologie Pub Date : 2025-09-01 Epub Date: 2025-08-22 DOI: 10.1007/s00120-025-02653-y

Friedrich H Moll, Erki Tammiksaar, Giacomo Padrini, Thorsten Halling, Nils Hansson

引用次数: 0

[The 77th Congress of the German Society of Urology]. [第77届德国泌尿外科学会大会]。

IF 0.4 4区医学

Urologie Pub Date : 2025-09-01 Epub Date: 2025-08-29 DOI: 10.1007/s00120-025-02655-w

Bernd Wullich

引用次数: 0

Erratum zu: 4/w mit Bauchschmerzen nach Verkehrsunfall. 事故后腹痛的错误率为4/w。

IF 0.4 4区医学

Urologie Pub Date : 2025-09-01 DOI: 10.1007/s00120-025-02680-9

Elisabeth Bartolf

引用次数: 0

Mitteilungen der DGU. DGU通讯。

IF 0.4 4区医学

Urologie Pub Date : 2025-09-01 DOI: 10.1007/s00120-025-02664-9

引用次数: 0

[Effectiveness of pelvic floor muscle training with feedback or biofeedback for urinary incontinence in women: a systematic review]. [骨盆底肌肉训练与反馈或生物反馈对女性尿失禁的有效性：系统综述]。

IF 0.4 4区医学

Urologie Pub Date : 2025-09-01 Epub Date: 2025-08-04 DOI: 10.1007/s00120-025-02658-7

Jennifer Kranz

引用次数: 0

[Occlusive azoospermia in unilateral cystic alteration of the seminal vesicle and contralateral seminal vesicle agenesis-case report]. [单侧精囊改变和对侧精囊发育不全的闭塞性无精子症- 1例报告]。

IF 0.4 4区医学

Urologie Pub Date : 2025-09-01 Epub Date: 2025-04-14 DOI: 10.1007/s00120-025-02578-6

Clarissa Wittler, D Engeler, J Rührup

引用次数: 0

[Bispecific antibodies in prostate cancer therapy]. 双特异性抗体在前列腺癌治疗中的应用

IF 0.4 4区医学

Urologie Pub Date : 2025-09-01 Epub Date: 2025-04-02 DOI: 10.1007/s00120-025-02574-w

Susanne Jung, Jonas Heitmann, Martin Pflügler, Gundram Jung, Steffen Rausch, Helmut Salih

{"title":"[Bispecific antibodies in prostate cancer therapy].","authors":"Susanne Jung, Jonas Heitmann, Martin Pflügler, Gundram Jung, Steffen Rausch, Helmut Salih","doi":"10.1007/s00120-025-02574-w","DOIUrl":"10.1007/s00120-025-02574-w","url":null,"abstract":"Prostate cancer (PC) is the second most common cancer in men. As soon as androgen deprivation therapy fails, treatment options are limited. Despite intense efforts, hardly any of the T cell-based immunotherapeutic strategies that have revolutionized oncological treatment in other cancer entities are yet established for the treatment of PC. This includes immune checkpoint inhibition, which generally reinforces T cell-immunity but failed to achieve broad activity in PC, as well as chimeric antigen receptor T (CART) cells and bispecific antibodies (bsAbs), which specifically mobilize T cells against tumor cells. Compared to CART cells, bsAbs have the advantage of being readily available \"off-the-shelf\" reagents. Currently several bispecific constructs are in development for PC. While development of some was discontinued due to substantial side effects or development of anti-drug antibodies, others have yielded promising results. These include in particular bsAbs directed against six-transmembrane epithelial antigen of the prostate 1 (STEAP1) and prostate-specific membrane antigen (PSMA), which are currently being evaluated in both patients with metastasized disease and biochemical relapse. The concepts underlying the different constructs, the current status of clinical development, and future perspectives are discussed.","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"933-939"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12394249/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143765291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Shared decision making-strengthening patient-physiciant relations through joint deliberation]. 【共同决策——通过共同协商加强医患关系】。

IF 0.4 4区医学

Urologie Pub Date : 2025-09-01 Epub Date: 2025-07-21 DOI: 10.1007/s00120-025-02638-x

Pola Hahlweg

{"title":"[Shared decision making-strengthening patient-physiciant relations through joint deliberation].","authors":"Pola Hahlweg","doi":"10.1007/s00120-025-02638-x","DOIUrl":"10.1007/s00120-025-02638-x","url":null,"abstract":"The aim of this article is to present shared decision making as a practical concept for urology. It describes a communication process in which patients and physicians share their respective perspective and expertise in order to jointly make an informed decision that is suitable for the individual patient. This makes it an important component of person-centered healthcare and is demanded by many patients and healthcare policy makers. Shared decision making can have a positive impact on patient knowledge and satisfaction. In urology, there are numerous decision-making situations in which shared decision making is indicated. At the same time, it is unclear how often shared decision making takes place in routine urological care and there are barriers to implementation on the part of physicians, patients and the organizational and system level. An appropriate attitude and communication skills as well as an awareness of the preference-sensitive decisions to be made are important prerequisites for shared decision making. Approaches such as the \"Three Talks\" model can be used to guide consultations. In addition, other measures such as patient decision aids, patient activation strategies, and training for physicians can support shared decision making in practice. Targeted approaches and reliable implementation in routine care will be important topics for the future of shared decision making.","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"909-916"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144675978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Funding year 2024/2025: overview of new DGU fellowships]. [资助年度2024/2025:DGU新奖学金概况]。

IF 0.4 4区医学

Urologie Pub Date : 2025-09-01 Epub Date: 2025-07-28 DOI: 10.1007/s00120-025-02660-z

Christoph Becker

引用次数: 0

[Digital urology : Possible uses for artificial intelligence and digital health applications]. [数字泌尿外科：人工智能和数字健康应用的可能用途]。

IF 0.4 4区医学

Urologie Pub Date : 2025-09-01 Epub Date: 2025-07-14 DOI: 10.1007/s00120-025-02651-0

Emily Rinderknecht, R Alexa, N Carl, M Goertz, F Wessels, H Borgmann

{"title":"[Digital urology : Possible uses for artificial intelligence and digital health applications].","authors":"Emily Rinderknecht, R Alexa, N Carl, M Goertz, F Wessels, H Borgmann","doi":"10.1007/s00120-025-02651-0","DOIUrl":"10.1007/s00120-025-02651-0","url":null,"abstract":"Background: Urology presents itself as a modern and future-oriented discipline. Artificial intelligence (AI) is becoming increasingly important in the field of digital urology. It enables the analysis of large medical data sets, such as histological patterns, imaging or molecular markers. In addition, large language models (LLMs) are opening up new fields of application. Digital health applications (DiGA) are also becoming increasingly important.Objectives: This article provides an overview of current developments in digital urology. The focus is on the possible applications of AI and LLMs, taking into account the legal and ethical framework, as well as an overview of the therapeutic landscape of DiGA in urological care.Methods: Existing AI models and applications will be presented and analyzed. In addition, DiGA in urological care and current regulatory requirements are discussed.Results: AI systems can improve many areas of urology-for example through automated evaluation of image morphology and histology data or voice-based applications in documentation and communication. DiGA support the follow-up care and treatment of urological diseases. Their use requires transparency, data protection, and quality assurance.Conclusion: AI and digital applications offer new care models and can help to increase efficiency. Challenges exist in terms of data quality, information technology infrastructure and the safe and responsible use of technologies. Future developments should be interdisciplinary.","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"900-908"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144638294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0